AffyImmune Therapeutics is a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers.

Biotechnology

AffyImmune Therapeutics

AffyImmune Therapeutics' headquarters in Natick, MA, United States

Moonsoo Jin

Victoria Begoun

Robert Forrester

Simone Song

Gang Song

James Mulé

Cassian Yee

Keith L. Knutson

The Scientific Team at AffyImmune Therapeutics specializes in researching and developing CAR T cell therapies to combat solid cancers. They focus on the cellular manufacturing process (CMC), advising on scientific strategies, overseeing translational medicine efforts, and ensuring the safe and effective clinical application of therapeutic discoveries.

Scientific Team

The Clinical Development team at AffyImmune Therapeutics is responsible for designing, implementing, and managing clinical trials to evaluate the efficacy and safety of CAR T cell therapies against solid cancers. This includes trial planning, data management, regulatory compliance, and operational oversight to advance therapeutic candidates through various stages of clinical development.

Clinical Development

The Leadership Team at AffyImmune Therapeutics is responsible for setting the strategic direction and vision of the company, guiding its clinical development efforts, and overseeing corporate governance. Comprised of co-founders with deep expertise in biotechnology and oncology, the team focuses on driving innovation in CAR T cell therapies to ensure the advancement of safe and effective treatment solutions for solid tumors.

AffyImmune Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Clinical Development

Leadership Team

Offices

AffyImmune Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Clinical Development

Leadership Team

Offices

Related companies